Related Experiment Video
Updated: Jun 10, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Patient with Fabry disease undergoing cardiac surgery: a word of caution
Jelena Vuckovic1,2, Anastazija Stojsic Milosavljevic1,2, Mirka Lukic-Sarkanovic1,3
1Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia.
Insights
Fabry disease (FD), a genetic disorder, can cause severe aortic valve issues. This case highlights FD
Area of Science:
- Genetics
- Biochemistry
- Cardiology
Background:
- Fabry disease (FD) is a rare X-linked genetic disorder caused by deficient alpha-galactosidase A (AGAL) activity.
- This deficiency leads to the accumulation of globotriaosylceramide (Gb3) in lysosomes, impacting multiple organ systems.
- FD presents with diverse clinical phenotypes, from severe classic forms to milder non-classical presentations.
Observation:
- A 23-year-old male patient with a history of kidney transplantation and chronic hemodialysis was admitted due to severe aortic regurgitation.
- The patient presented with suspected aortic valve endocarditis and vegetations posing a high embolic risk.
- The patient's kidney graft had failed one year post-transplantation.
Findings:
- The case underscores the potential for severe cardiovascular complications in Fabry disease, specifically aortic valve involvement.
- The patient's history of kidney transplantation and graft failure highlights the systemic impact of FD.
- The presence of vegetations indicates a critical cardiac event requiring urgent management.
Implications:
- This case emphasizes the importance of early diagnosis and comprehensive management of Fabry disease to prevent severe organ damage.
- Cardiovascular surveillance is crucial for FD patients, particularly for detecting valvular abnormalities.
- Understanding the heterogeneity of FD phenotypes is essential for tailoring patient care and prognosis.
Abstract:
Fabry disease (FD) is a rare genetic disorder that affects various organs and systems in the body. The disease is caused by a deficiency in the lysosomal enzyme α-galactosidase A (AGAL), which leads to the accumulation of globotriaosylceramide (Gb3) within lysosomes. This accumulation can cause damage to cells and organ systems, leading to a wide range of symptoms and complications. FD is a heterogeneous disorder, with a wide range of clinical phenotypes, ranging from the classic form, which is severe and associated with early onset, to milder non-classical forms, which are often limited to one organ and manifest later in life. We describe the case of a 23-year-old FD patient who was admitted as an emergency transfer due to newly discovered severe aortic regurgitation and suspected aortic valve endocarditis with vegetations of high embolic potential. Three years ago, the patient underwent a living donor kidney transplantation-the kidney graft lost its function 1 year after transplantation, and a chronic hemodialysis program was reinstituted.
Supplementary Information:
The online version contains supplementary material available at 10.1007/s12055-024-01717-6.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aneurysm IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Imaging Studies for Cardiovascular System V: CT

